Name of Drug

Classificati on

Dosage/Ro ute/ Frequency/
40 mg. p.o. OD

Mechanis m of action
Blocks the vasoconstricti ve and aldosteronesecreting effects of angiotensin II by selectively blocking the binding of angiotensin II to angiotensin I receptor in many tissues.

Indicatio n

Contraindica tion

Adverse effect

Nursing intervention

(Telmisartan) Micardis

Cardiovascular Drugs Angiotensin II Antagonists

Treatment of hypertension

• •

Presence of hematopoietic disorders History of thrombotic thrombocytop enic purpura (TTP) Presence of hemostatic disorder or active pathologic bleeding Severe liver impairment

Headache, rash, pruritus, nausea, fullness, dyspepsia, GI pain, flatulence, anorexia. Prolonged bleeding time, bleeding complications. Weakness, pain.

Assessment: • Assess patient’s condition before therapy. • Assess for heart failure. • Obtain baseline and liver status before therapy. Implementation: • Instruct patient to comply with dosage schedule even if feeling better. • Tell patient that drug may cause lightheadedness, dizziness and fainting. • Instruct • patient with heart failure to report decreased urine output. • Teach patient the importance of diet control.

constipation. an essential component in formation of hemoglobin in red blood cell development.Name of Drug Classificati on Dosage/Ro ute/ Frequency/ 1 tab p. Indicatio n Contraindica tion Adverse effect Nursing intervention (Ferrous Sulfate) AMEuropharma Ferrous Sulfate. hemolytic anemia.o. Mechanis m of action Provides/Repl aces elemental iron. Brofesol. hemosiderosis. Implementation: • Instruct patient not to substitute one iron salt for another because they have different elemental iron content. dark stool. Hypersensitivity to any ingredient. Ferglobin. diarrhea. . epigastric pain. constipation. GI irritation. TID p. black stool. • Monitor for adverse reaction: GI: nausea. anorexia. Assessment: • Obtain baseline assessment of iron deficiency. Anemicon. Teeth staining with liquid formulation. Rhea Ferrous Sulfate Dietary/Nutrition al Preparations Hematinics Prevention and treatment of irondeficiency anemia. • Assess diet and nutrition.c. Fer-In-Sol. diarrhea. Feosol spansule. anorexia.

Headache. Subcutaneous Injection 2x a week (Wednesday and Saturday) Mechanis m of action Mimics effects of erythropoietin which functions as a growth factor and as a differentiating factor. skin rashes Assessment: • Monitor renal and blood studies. Shortness of breath. enhancing RBC production. vomiting. • Monitor B/P Implementation: • Advise patients to take iron supplements. including anaphylaxis. Name of Drug Classificati on Dosage/Ro ute/ Frequency/ 4000 I. Hypersensitivity to mammalian cellderived products or human albumin. they may reduce or obviate the need for blood transfusions in these patients. tachycardia. clotted vascular access. • Assess for CNS symptom: coldness. Hypertension. drug is developed by recombinant DNA Indicatio n Contraindica tion Adverse effect Nursing intervention (EPO) Eprex Hematopoietic Growth Factors Management of anemia associated with chronic renal failure in dialysis and predialysis patients. uncontrolled hypertension.U.• Instruct patient to swallow the whole tablet and not to double the dose if missed. . seizures. sweating. pain in long bones. Nausea. diarrhea. Allergy.

fever. and Should not be used when stimulation of muscular contractions might adversely affect GI conditions as in GI hemorrhage. • Instruct patient to report signs or symptoms of edema. Implementation: . Assessment: • Assess for GI complaints. Vit. B12. and urticaria. Perforation.technology. The incidence of central effects such as extrapyramida l reactions or drowsiness may be lower than metocloprami de. paresthesia. obstruction. or immediately after surgery. TID Mechanis m of action Selectively blocks peripheral dopamine receptors in the GI wall and in the chemorecepto r-tor trigger zone (CTZ) thus enhancing Indicatio n Contraindica tion Adverse effect Nursing intervention (Domperidon e) Antiemetic/ Antivertigo Motilium Anti-emetic for the shortterm treatment of nausea and vomiting of various etiologies. Also used in the management of chemotherap y-induced anemia in patients with non-myeloid malignant disease. • Assess for pain. including that associated with cancer therapy. and folic acid as directed. Name of Drug Classificati on Dosage/Ro ute/ Frequency/ 1 tab p. arthralgia.o. • Assess for change in bowel habits.

Antacid. • Implementation: . strengthens gastric mucosal barrier and reduce pepsin Indicatio n Contraindica tion Adverse effect Nursing intervention (Calcium carbonate) Calci-Aid. Hypercalcemia Constipation. • Instruct the patient to inform the physician if transient intestinal cramps. osteoporosis. flatulence and rebound hyperacidity. calcium Sandoz chewable tablet. increased plasma prolactin levels and extrapyramidal symptoms occur. Assessment: Assess for adverse reactions: constipation.normal synchronized GI peristalsis and motility in the proximal region of the GIT.o. counteract anticholinergicinduced relaxation of the lower esophageal sphincter. gastric hypersecretio n. Calsan Vitamins and Minerals q 6 hrs. Mechanis m of action Decreases total acid load of GI tract. nausea and vomiting associated with levodopa or bromocriptin e therapy for parkinsonism . Increases esophageal sphincter tone. diarrhea. • Inform the patient to take the medication before meals. flatulence. Also used for its prokinetic actions in disorders of gastrointestin al motility. • Assess for nausea and vomiting. gastric distention. Name of Drug Classificati on Dosage/Ro ute/ Frequency/ 1 tab p. hyperphosph atemia. calcium supplement.

• Tell patient to notify physician of persistent symptoms like tarry stools or coffee ground vomitus. hives. swelling or inflammation. Name of Drug Classificati on Dosage/Ro ute/ Frequency/ 160-200 4 “u” 201-240 6 “u” 241-280 8 “u” >282 10 “u” Subcutaneous Mechanis m of action Decreases blood glucose. diabetic coma. Lipodystrophy. • Assess for . • Monitor body weight periodically. Hypoglycemia. insulin resistance. by transport of glucose into cells and the conversion of glucose to glycogen Indicatio n Contraindica tion Adverse effect Nursing intervention (Insulin) Humulin R Anti-diabetic drugs Short-acting insulin Management of type 1 DM or insulin dependent DM (IDDM) and type 2 DM or noninsulindependent Hypoglycemia. after meals. unless contraindicated. temporary visual impairment. itching. • Advise patient to take as directed.activity by elevating gastric pH. redness. • Advise patient to increase fluids to 2 l. 2 hrs. pain. insulinoma. Assessment: • Monitor fasting blood glucose. to add bulk to diet for constipation. hypersensitivity reactions.IV administration of insulin suspension.

hypoglycemic reactions that can occur during peak time. • . decreases phosphate and potassium. • Tell patient not to stop insulin therapy without medical approval. Implementation: Instruct patient on proper technique for administration. exercise or weight reduction alone. flushed. • Observe injection sites for signs and symptoms of local hypersensitivity such as redness.indirectly increases blood pyruvate and lactate. or burning. fatigue. • Assess for hyperglycemia: acetone breath. dry skin. DM (NIDDM)whic h cannot be controlled by diet. polydipsia. lethargy. polyuria. itching.

. Ms.m. Sheryl G.Drug Study Realino.I. 2-10 p. 8 C. Bautista IV – 2 Grp.

Sign up to vote on this title
UsefulNot useful